Skip to main content
. 2024 Apr 16;10(3):e12371. doi: 10.1002/2056-4538.12371

Figure 3.

Figure 3

Scatterplot of PD‐L1 TPS versus CID in (A) pembrolizumab‐treated patients (n = 309), (B) chemotherapy‐treated patients (n = 292), and (C) all patients (N = 601).